New technologies can potentially save lives by helping identify prostate cancer earlier, and transforming the way doctors detect and track cancerous cells. Prostate cancer is the most common cancer ...

Stockholm3 blood test detected 90% of aggressive prostate cancer cases compared to 74% for PSA tests in a study of over ...

A new study suggests the investigational Stockholm3 blood test may improve the early detection of aggressive prostate cancer ...

A pioneering blood test detected more than twice as many high-risk prostate cancer cases as current methods, paving the way for more effective screening.

The major challenge in prostate cancer screening is not just to find more cancer cases, but to identify the cancers that are ...

A large analysis suggests that a multivariable risk assessment tool, called Stockholm3, can detect substantially more ...

A next-generation Stockholm3 blood test detected aggressive prostate cancer more accurately than PSA, improving early ...

A new blood test may make it easier to detect the most dangerous forms of prostate cancer early. In a study from Karolinska ...

The study's testing accurately identified prostate cancer 91% of the time and accurately ruled out men without prostate cancer 84% of the time. A urine-based biomarker panel may be a promising, ...

Prostate cancer is the most common cancer in Australia, with about 26,000 men diagnosed per year. The majority (more than 85%) are aged over 60. Prostate cancer kills around 3,900 Australians a year.